Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 28, 2024Open Access

Clinical efficacy and safety of vasopressin and its analogues in patients with septic shock: a meta-analysis and trial sequential analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

MDMilan DongSLShaojun LiJJJing Jiang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dong et al. (2024) studied this question.

synapsesocial.com/papers/68e77418b6db6435876e8bbchttps://doi.org/10.21203/rs.3.rs-3985419/v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Vasopressin in Pediatric Vasodilatory Shock: A Multicenter Randomized Controlled Trial2009 · 144 citations
  2. 2RoB 2: a revised tool for assessing risk of bias in randomised trials2019 · 33,351 citations
  3. 3Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock2018 · 208 citations
  4. 4The effects and safety of vasopressin receptor agonists in patients with septic shock: a meta-analysis and trial sequential analysis2019 · 39 citations
  5. 5Comparison of Norepinephrine and Terlipressin vs Norepinephrine Alone for Management of Septic Shock: A Randomized Control Study2022 · 21 citations